2012
DOI: 10.1007/s13193-012-0172-0
|View full text |Cite
|
Sign up to set email alerts
|

Primary Osteogenic Sarcoma of the Breast: A Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Forty-one per cent of patients with POSB develop metastases which highlight the need for effective adjuvant therapy [6]. The role of chemotherapy in the management of patients with POSB is uncertain with limited reports in the literature with differing regimens and outcomes [22][23][24][25][26]. However, because of the dramatic improvement in survival from chemotherapy administration for patients with primary osteosarcoma of the bone, it is reasonable to consider its use for a patient with POSB until better evidence is available to guide management [22].…”
Section: Case Reports In Surgerymentioning
confidence: 99%
“…Forty-one per cent of patients with POSB develop metastases which highlight the need for effective adjuvant therapy [6]. The role of chemotherapy in the management of patients with POSB is uncertain with limited reports in the literature with differing regimens and outcomes [22][23][24][25][26]. However, because of the dramatic improvement in survival from chemotherapy administration for patients with primary osteosarcoma of the bone, it is reasonable to consider its use for a patient with POSB until better evidence is available to guide management [22].…”
Section: Case Reports In Surgerymentioning
confidence: 99%